Notably, the inhibitory receptors CTLA-4 and PD-1 act to constrain autoimmunity, and their inhibition has been reported to initiate or exacerbate sarcoid-like inflammation, reinforcing the notion of altered immune activation and, possibly, an autoimmune component in sarcoidosis [12]. Here, CTLA4 is linked to sarcoidosis.